The Johns Hopkins Scleroderma Center is a research-focused, collaborative effort involving faculty of the Division of Rheumatology and other members of the Johns Hopkins Medical Institutions. Basic research, translational research, and clinical trial are all underway at The Johns Hopkins Scleroderma Center.
These publications represent research by researchers and clinicians of The Johns Hopkins Scleroderma Center.
Clinical trials involving scleroderma patients are planned or ongoing.
Basic and translational research are the route to new discoveries and treatments.
Physicians from The Johns Hopkins Scleroderma Center work closely with colleagues from around the nation.